Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.160
-0.080 (-3.57%)
At close: Jun 27, 2025, 4:00 PM
2.260
+0.100 (4.63%)
After-hours: Jun 27, 2025, 4:05 PM EDT
Apyx Medical Revenue
Apyx Medical had revenue of $9.43M in the quarter ending March 31, 2025, a decrease of -7.95%. This brings the company's revenue in the last twelve months to $47.29M, down -6.27% year-over-year. In the year 2024, Apyx Medical had annual revenue of $48.10M, down -8.11%.
Revenue (ttm)
$47.29M
Revenue Growth
-6.27%
P/S Ratio
1.76
Revenue / Employee
$214,945
Employees
220
Market Cap
81.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 48.10M | -4.25M | -8.11% |
Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
APYX News
- 4 weeks ago - Renuvion® Brings Real Transformations to the Runway at Miami Swim Week - PRNewsWire
- 6 weeks ago - Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™ - GlobeNewsWire
- 6 weeks ago - Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Renuvion Introduces Television Star Dolores Catania as Chief of Confidence - PRNewsWire
- 2 months ago - Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures - GlobeNewsWire
- 2 months ago - Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 3 months ago - Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener" - PRNewsWire
- 3 months ago - Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript - Seeking Alpha